Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.

John HughesDiana Y Y ChiuPhillip A KalraDarren Green

Published in: PloS one (2018)

No specific PPI drugs show a favourable profile in regards of risk for hypomagnesaemia in CKD. Avoiding concurrent use of PPI and thiazide may be of value in patients with hypomagnesaemia.

Keyphrases

protein protein
chronic kidney disease
risk factors
small molecule
locally advanced
type diabetes
metabolic syndrome
adipose tissue
skeletal muscle